Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Revenue

Aquestive Therapeutics had revenue of $12.81M in the quarter ending September 30, 2025, a decrease of -5.43%. This brings the company's revenue in the last twelve months to $43.40M, down -26.32% year-over-year. In the year 2024, Aquestive Therapeutics had annual revenue of $57.56M with 13.80% growth.

• Revenue (ttm): $43.40M
• Revenue Growth: -26.32%
• P/S Ratio: 7.41
• Revenue / Employee: $305,613
• Employees: 142
• Market Cap: 387.97M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	57.56M	6.98M	13.80%
Dec 31, 2023	50.58M	2.90M	6.09%
Dec 31, 2022	47.68M	-3.15M	-6.20%
Dec 31, 2021	50.83M	4.98M	10.87%
Dec 31, 2020	45.85M	-6.76M	-12.85%
Dec 31, 2019	52.61M	-14.82M	-21.98%
Dec 31, 2018	67.43M	512.00K	0.77%
Dec 31, 2017	66.92M	15.13M	29.22%
Dec 31, 2016	51.79M	49.07M	1,807.37%
Dec 31, 2006	2.72M	592.00K	27.89%
Dec 31, 2005	2.12M	-	-